Preview

Cardiovascular Therapy and Prevention

Advanced search

Microcirculation in arterial hypertension patients receiving beta-adrenoblockers

Abstract

Aim. To compare microcirculation (MC) functional status during the treatment with beta-adrenoblockers (BAB), with and without vasodilatatory effects, in patients with Stage I-II arterial hypertension (AH). Material and methods. In total, 61 Stage I-II patients and 30 relatively healthy volunteers were examined. AH patients received nebivolol or metoprolol for 24 weeks. At baseline, and after 4, 12, and 24 weeks, MC hemodynamic types (MCHT) were assessed by laser Doppler flowmetry (LAKK-02 device, “LASMA”, Russia). Ключевые слова: артериальная гипертония, состояние микроциркуляции, гемодинамические типы микроциркуляции, β-адреноблокаторы, небиволол, метопролол. Results. AH is characterized by heterogeneous MC changes: hyperemic MCHT is typical for Stage I AH, and stasis-congestive or spastic MCHT – for Stage II AH. During metoprolol therapy, normocirculatory MCHT increased, and hyperemic MCHT decreased. Nebivolol demonstrated normalizing effects, manifesting in decreased hyperemic or spastic MCHT and increased normocirculatory MCHT. Conclusion. Metoprolol improved MC functional status. Nebivolol normalized functional and morphological MC status.

About the Authors

L. L. Kirichenko
Moscow State Medico-Stomatological University. Moscow
Russian Federation


O. V. Vostryakova
Moscow State Medico-Stomatological University. Moscow
Russian Federation


Yu. A. Babich
Moscow State Medico-Stomatological University. Moscow
Russian Federation


N. V. Burlyay
Moscow State Medico-Stomatological University. Moscow
Russian Federation


Zh. I. Vasheva
Moscow State Medico-Stomatological University. Moscow
Russian Federation


A. P. Korolev
Moscow State Medico-Stomatological University. Moscow
Russian Federation


O. B. Golovkova
Moscow State Medico-Stomatological University. Moscow
Russian Federation


References

1. Мареев В.Ю., Беленков Ю.Н. Должны ли изменяться взгляды российских врачей на принципы лечения артериальной гипертонии в свете результатов исследования ALLHAT. Сердце 2003; 2(1): 38-44.

2. Маколкин В.И., Подзолков В.И., Бранько В.В., Самойленко В.В. Микроциркуляция в кардиологии. Москва: Визарт 2004; 136 с.

3. Prichard B, Cruickshank J, Graham B. Beta–adrenergic blocking drugs in the treatment of hypertension. Blood Pressure 2001; 10: 366-86.

4. Schiffrin EL, Deng LY, Larochelle P. Effect of a beta-blocer o ACEi on resistance arteries. Hypertension 1994; 23: 83-91.

5. Winther K, Klysner R, Geisler A, Andersen PH. Characterisation of human platelet beta- adrenoceptors. Thromb Res 1995; 40: 757-67.

6. Turacli О, Struijer-Boudier H, Noble J, et al. The microcirculation and hypertension. J Hypertens 1992; 10: S147-56.

7. Маколкин В.И., Подзолков В.И., Павлов В.И., Самойленко В.В. Состояние микроциркуляции при гипертонической болезни. Кардиология 2003; 5: 60-7.


Review

For citations:


Kirichenko L.L., Vostryakova O.V., Babich Yu.A., Burlyay N.V., Vasheva Zh.I., Korolev A.P., Golovkova O.B. Microcirculation in arterial hypertension patients receiving beta-adrenoblockers. Cardiovascular Therapy and Prevention. 2006;5(6):27-31. (In Russ.)

Views: 393


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)